In prostate cancer, MUC1-C has been shown to activate the BAF complex in prostate cancer stem cells, enhancing the expression of NOTCH1 and NANOG, thus promoting self-renewal of tumor stem cells and accelerating the progression of neuroendocrine prostate cancer (15). Here, NANOG is linked to prostate carcinoma.